Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 18Breast 14Tumor-Agnostic 13Other hematologic neoplasm 12Gynecologic 12Genitourinary 11Lymphoid 8Thoracic 7Head & Neck 7Sarcoma 4Plasma cell 4Other solid neoplasm 4Other 3Dermatologic 3CNS 3Other neoplasm 2Myeloid 1Classical hematology 1

Conditions

Melanoma 2Identification of Skin Cancer Biopsy Sites 1

Interventions

Ipilimumab 123pembrolizumab 100Nivolumab 100aldesleukin 89Cyclophosphamide 85fludarabine phosphate 64Interleukin-2 58Dacarbazine 573-ingenyl angelate 42Vemurafenib 39Temozolomide 39Imiquimod 39trametinib 37sargramostim 37Peripheral Blood Stem Cell Transplantation 36incomplete Freund's adjuvant 35dabrafenib 32fludarabine 31Radiotherapy 31Aminolevulinic Acid 30Bevacizumab 29Carboplatin 28Whole-Body Irradiation 25Photochemotherapy 25Paclitaxel 25Filgrastim 25Biopsy 25Interferon-alpha 24Cisplatin 23Sorafenib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interviews as Topic × Dermatologic × Clear all
NCT01632644 2021-12-06

Identifying Skin Biopsy Sites

Northwestern University

Completed
59 enrolled
Dermatologic

Identification of Skin Cancer Biopsy Sites

NCT00510302 2020-09-16

Melanoma Risk-Reduction Among Patients and Family Members

M.D. Anderson Cancer Center

Completed
170 enrolled
Dermatologic

Melanoma

NCT00394134 2019-09-13

Targeted Intervention for Melanoma Prevention

M.D. Anderson Cancer Center

Phase NA Completed
205 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡